Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131413) titled 'Research on the Construction of a Comprehensive Management System and Precision Intervention Strategies for Bladder Cancer Patients' on Sept. 2.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology
Condition:
Patients with bladder cancer who require bladder instillation therapy
Intervention:
symptomanalysis group:None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-15
Target Sample Size: symptomanalysis group:320;Scale validation group:280;
Countries of Recr...